NASDAQ:ABP Abpro (ABP) Stock Price, News & Analysis $0.21 -0.02 (-7.83%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Abpro Stock (NASDAQ:ABP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Abpro alerts:Sign Up Key Stats Today's Range$0.20▼$0.2350-Day Range$0.17▼$0.4852-Week Range$0.15▼$13.00Volume2.58 million shsAverage Volume5.71 million shsMarket Capitalization$11.07 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company OverviewAbpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.Read More… Receive ABP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abpro and its competitors with MarketBeat's FREE daily newsletter. Email Address ABP Stock News HeadlinesNasdaq Top 5 Premarket Gainers: Clik Holdings, Graphjet Technology, NuCana, Ekso Bionics Holdings, Abpro HoldingsMay 15, 2025 | msn.comAbpro Holdings, Celltrion unveils preclinical data for ABP-102/CT-P72April 28, 2025 | markets.businessinsider.com52 Money Mondays for $7 (This Weekend Only)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’s “Most Wanted” trader, who just put the finishing touches on his brand-new Money Monday algorithm.May 24, 2025 | Timothy Sykes (Ad)Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell EngagerApril 27, 2025 | globenewswire.comAbpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025March 25, 2025 | globenewswire.comAbpro Corporation: Abpro Statement on the Departure of Former CEO Ian ChanMarch 11, 2025 | finanznachrichten.deAbpro Holdings announces departure of CEO Ian ChanMarch 10, 2025 | markets.businessinsider.comAbpro Statement on the Departure of Former CEO Ian ChanMarch 10, 2025 | globenewswire.comSee More Headlines ABP Stock Analysis - Frequently Asked Questions How have ABP shares performed this year? Abpro's stock was trading at $1.79 at the beginning of the year. Since then, ABP stock has decreased by 88.2% and is now trading at $0.2120. View the best growth stocks for 2025 here. How were Abpro's earnings last quarter? Abpro Co. (NASDAQ:ABP) issued its earnings results on Thursday, May, 15th. The company reported ($0.08) EPS for the quarter. When did Abpro IPO? Abpro (ABP) raised $60 million in an initial public offering (IPO) on Friday, May 11th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Nomura and Oppenheimer were co-managers. Who are Abpro's major shareholders? Abpro's top institutional investors include Goldman Sachs Group Inc. (0.14%). View institutional ownership trends. How do I buy shares of Abpro? Shares of ABP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2025Today5/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Holding & other investment offices Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ABP CIK1893219 Webwww.atlanticcoastalacquisition.com Phone248-890-7200FaxN/AEmployees15Year FoundedN/APrice Target and Rating Average Stock Price Target$4.00 High Stock Price Target$4.00 Low Stock Price Target$4.00 Potential Upside/Downside+1,786.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$183,000.00 Price / Sales60.49 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares52,219,000Free Float4,565,000Market Cap$11.07 million OptionableN/A Beta-0.01 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:ABP) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abpro Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abpro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.